Ironwood Pharmaceuticals
IRWD
IRWD
221 hedge funds and large institutions have $2.09B invested in Ironwood Pharmaceuticals in 2022 Q1 according to their latest regulatory filings, with 39 funds opening new positions, 67 increasing their positions, 78 reducing their positions, and 29 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
0.39% less ownership
Funds ownership: 105.03% → 104.64% (-0.39%)
14% less repeat investments, than reductions
Existing positions increased: 67 | Existing positions reduced: 78
68% less call options, than puts
Call options by funds: $238K | Put options by funds: $734K
Holders
221
Holding in Top 10
2
Calls
$238K
Puts
$734K
Top Buyers
| 1 | +$15.5M | |
| 2 | +$11.2M | |
| 3 | +$9.06M | |
| 4 |
RA
Royce & Associates
New York
|
+$8.55M |
| 5 |
Two Sigma Advisers
New York
|
+$7.83M |
Top Sellers
| 1 | -$35M | |
| 2 | -$26.7M | |
| 3 | -$25.5M | |
| 4 |
Goldman Sachs
New York
|
-$8.72M |
| 5 |
FP
Foundry Partners
Minneapolis,
Minnesota
|
-$7.14M |